Predict your next investment

Venture Capital
bioadvance.com

See what CB Insights has to offer

Investments

99

Portfolio Exits

14

Funds

1

About BioAdvance

BioAdvance provide early-stage capital for companies located in the mid-Atlantic region that are developing technologies to improve human health.

BioAdvance Headquarter Location

3711 Market Street 8th Floor

Philadelphia, Pennsylvania, 19104,

United States

610-230-0544

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest BioAdvance News

Senzo Secures a $2mm Pre-Series A Financing Led by Bioadvance to Progress Its Breakthrough Lateral Flow Diagnostic Testing Platform for Covid-19, Flu A/B, Tuberculosis, HIV

Jul 25, 2022

Senzo, a life sciences company developing high accuracy, low-cost point-of-care diagnostic technologies, today announced a $2 million equity funding round led by BioAdvance, a leading life science venture capital firm. Wellness Coaches, a national provider of health and wellness solutions, including point-of-care diagnostics testing to public and private organizations, also participated in the round.   The post Senzo Secures a $2mm Pre-Series A Financing Led by Bioadvance to Progress Its Breakthrough Lateral Flow Diagnostic Testing Platform for Covid-19, Flu A/B, Tuberculosis, HIV appeared first on BioBuzz.

BioAdvance Investments

99 Investments

BioAdvance has made 99 investments. Their latest investment was in Senzo as part of their Seed VC on July 7, 2022.

CBI Logo

BioAdvance Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

7/21/2022

Seed VC

Senzo

$2M

Yes

2

7/11/2022

Series C

Halo Labs

$6M

No

7

3/16/2022

Series A

KayoThera

$8M

Yes

8

6/5/2020

Series A

Subscribe to see more

$99M

Subscribe to see more

10

5/28/2020

Series C

Subscribe to see more

$99M

Subscribe to see more

10

Date

7/21/2022

7/11/2022

3/16/2022

6/5/2020

5/28/2020

Round

Seed VC

Series C

Series A

Series A

Series C

Company

Senzo

Halo Labs

KayoThera

Subscribe to see more

Subscribe to see more

Amount

$2M

$6M

$8M

$99M

$99M

New?

Yes

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

2

7

8

10

10

BioAdvance Portfolio Exits

14 Portfolio Exits

BioAdvance has 14 portfolio exits. Their latest portfolio exit was PSS Industrial Group on May 23, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

5/23/2022

Acq - Fin

$99M

1

9/3/2021

Reverse Merger

$99M

4

11/4/2020

Acquired

$99M

1

10/2/2020

IPO

Subscribe to see more

$99M

Subscribe to see more

10

1/29/2020

IPO

Subscribe to see more

$99M

Subscribe to see more

10

Date

5/23/2022

9/3/2021

11/4/2020

10/2/2020

1/29/2020

Exit

Acq - Fin

Reverse Merger

Acquired

IPO

IPO

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

1

4

1

10

10

BioAdvance Fund History

1 Fund History

BioAdvance has 1 fund, including BioAdvance Ventures.

Closing Date

Fund

Fund Type

Status

Amount

Sources

BioAdvance Ventures

$26M

1

Closing Date

Fund

BioAdvance Ventures

Fund Type

Status

Amount

$26M

Sources

1

BioAdvance Team

3 Team Members

BioAdvance has 3 team members, including current Chief Executive Officer, Managing Director, Shahram Hejazi.

Name

Work History

Title

Status

Shahram Hejazi

Chief Executive Officer, Managing Director

Current

Barbara S. Schilberg

Managing Director

Current

Gary J. Kurtzman

Chief Operating Officer, Managing Director

Former

Name

Shahram Hejazi

Barbara S. Schilberg

Gary J. Kurtzman

Work History

Title

Chief Executive Officer, Managing Director

Managing Director

Chief Operating Officer, Managing Director

Status

Current

Current

Former

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.